Only use USP-grade pharmaceutical solvents for peptide injection reconstitution
BPC-157, TB-500, and thymosin alpha-1-1 represent the most clinically studied anti-inflammatory peptides, with research showing significant reductions in inflammatory markers within 7-14 days of treatment
PubMed Copper peptide and skin remodeling literature Used to keep skin and collagen claims connected to PubMed rather than cosmetic marketing alone
A lyophilized vial stored cold and away from light remains stable for substantially longer than a pre-mixed solution
Starting both compounds together from baseline If beginning both compounds from scratch, start retatrutide first
In addition, the marketed benefits of BPC-157 have only been shown in lab or animal studies (rats, mice, and dogs)